Gland Pharma Q4 results: Profit dips 3% YoY to ₹187 crore; 1800% dividend announced

Gland Pharma Q4 results: Gland Pharma's PAT came in at ₹187 crore for the quarter under review, as against ₹192 crore in the year-ago quarter, recording a 3% decline on a year-on-year basis.

Markets